Atea Pharmaceuticals, Inc. (AVIR): Weighted Average Diluted Shares
81.50M
Year ended 2025-12-31
-0.7%
3-year compound annual growth
+30.4%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 81.50M | -3.3% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | 84.26M | +1.0% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | 83.39M | +0.2% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | 83.25M | -5.7% | 2024-02-28, From 2022-01-01 |
| 2021-12-31 | 88.25M | +308.7% | 2023-02-28, From 2021-01-01 |
| 2020-12-31 | 21.59M | +114.0% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | 10.09M | n/a | 2022-02-28, From 2019-01-01 |